Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development

The bone morphogenetic protein (BMP) signaling pathways have important roles in embryonic development and cellular homeostasis, with aberrant BMP signaling resulting in a broad spectrum of human disease. We report that BMPs unexpectedly signal through the canonical transforming growth factor β (TGF‐β)‐responsive Smad2 and Smad3. BMP‐induced Smad2/3 signaling occurs preferentially in embryonic cells and transformed cells. BMPs signal to Smad2/3 by stimulating complex formation between the BMP‐binding TGF‐β superfamily receptors, activin receptor‐like kinase (ALK)3/6, and the Smad2/3 phosphorylating receptors ALK5/7. BMP signaling through Smad2 mediates, in part, dorsoventral axis patterning in zebrafish embryos, whereas BMP signaling through Smad3 facilitates cancer cell invasion. Consistent with increased BMP‐mediated Smad2/3 signaling during cancer progression, Smad1/5 and Smad 2/3 signaling converge in human cancer specimens. Thus, the signaling mechanisms used by BMPs and TGF‐β superfamily receptors are broader than previously appreciated.—Holtzhausen, A., Golzio, C., How, T., Lee, Y.‐H., Schiemann, W. P., Katsanis, N., Blobe, G. C. Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development. FASEB J. 28, 1248–1267 (2014). www.fasebj.org

[1]  Y. Henis,et al.  Oligomeric interactions of TGF‐β and BMP receptors , 2012, FEBS letters.

[2]  D. Langleben,et al.  Bone morphogenic protein-9 stimulates endothelin-1 release from human pulmonary microvascular endothelial cells: a potential mechanism for elevated ET-1 levels in pulmonary arterial hypertension. , 2010, Microvascular research.

[3]  P. Knaus,et al.  Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells. , 2010, The international journal of biochemistry & cell biology.

[4]  H. Guan,et al.  BMP‐3 promotes mesenchymal stem cell proliferation through the TGF‐β/activin signaling pathway , 2010, Journal of cellular physiology.

[5]  Dennis Brown,et al.  Dragon enhances BMP signaling and increases transepithelial resistance in kidney epithelial cells. , 2010, Journal of the American Society of Nephrology : JASN.

[6]  A. Matsuda,et al.  Endoglin is involved in BMP‐2‐induced osteogenic differentiation of periodontal ligament cells through a pathway independent of Smad‐1/5/8 phosphorylation , 2010, Journal of cellular physiology.

[7]  Kohei Miyazono,et al.  Bone morphogenetic protein receptors and signal transduction. , 2010, Journal of biochemistry.

[8]  Herbert Y. Lin,et al.  The RGM/DRAGON family of BMP co-receptors. , 2009, Cytokine & growth factor reviews.

[9]  Joachim Nickel,et al.  Receptor oligomerization and beyond: a case study in bone morphogenetic proteins , 2009, BMC Biology.

[10]  T. Ravikumar,et al.  Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. , 2009, Cancer letters.

[11]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[12]  R. Trembath,et al.  Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells* , 2009, The Journal of Biological Chemistry.

[13]  Gerard C Blobe,et al.  Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2. , 2009, Carcinogenesis.

[14]  R. Derynck,et al.  TGFβ‐stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro‐migratory TGFβ switch , 2009, The EMBO journal.

[15]  J. Inman,et al.  Bmc Cell Biology a Rapid and Sensitive Bioassay for the Simultaneous Measurement of Multiple Bone Morphogenetic Proteins. Identification and Quantification of Bmp4, Bmp6 and Bmp9 in Bovine and Human Serum , 2022 .

[16]  R. Randall,et al.  Transforming Growth Factor (cid:2) -Induced Smad1/5 Phosphorylation in Epithelial Cells Is Mediated by Novel Receptor Complexes and Is Essential for Anchorage-Independent Growth (cid:1) † , 2022 .

[17]  J. Engelhardt,et al.  Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation , 2008, Laboratory Investigation.

[18]  G. Blobe,et al.  Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-β Type III Receptor* , 2008, Journal of Biological Chemistry.

[19]  Brian Bierie,et al.  Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. , 2008, Cancer research.

[20]  Iñaki F Trocóniz,et al.  Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-beta kinase antagonist, in mice. , 2008, European journal of cancer.

[21]  Martin M. Matzuk,et al.  Conditional Deletion of Smad1 and Smad5 in Somatic Cells of Male and Female Gonads Leads to Metastatic Tumor Development in Mice , 2007, Molecular and Cellular Biology.

[22]  M. Nachtigal,et al.  BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. , 2007, Carcinogenesis.

[23]  R. Kalluri,et al.  BMP‐7 functions as a novel hormone to facilitate liver regeneration , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  S. Choe,et al.  Structure of the ternary signaling complex of a TGF-β superfamily member , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[26]  M. Reiss,et al.  Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. , 2005, Molecular biology of the cell.

[27]  S. Hayward,et al.  Loss of TGF-β type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α-, MSP- and HGF-mediated signaling networks , 2005, Oncogene.

[28]  H. Beppu,et al.  Bone Morphogenetic Protein (BMP) Type II Receptor Deletion Reveals BMP Ligand-specific Gain of Signaling in Pulmonary Artery Smooth Muscle Cells* , 2005, Journal of Biological Chemistry.

[29]  Gerard C Blobe,et al.  Role of transforming growth factor Beta in human cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  S. Hayward,et al.  Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. , 2005, Oncogene.

[31]  W. Sebald,et al.  Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction , 2004, Biological chemistry.

[32]  L. Wakefield,et al.  TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression , 2003 .

[33]  L. Wakefield,et al.  TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. , 2003, The Journal of clinical investigation.

[34]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[35]  A. Reith,et al.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.

[36]  W. Talbot,et al.  Morpholino phenocopies of the bmp2b/swirl and bmp7/snailhouse mutations , 2001, Genesis.

[37]  K. Lyons,et al.  Bone morphogenetic protein-3 is a negative regulator of bone density , 2001, Nature Genetics.

[38]  T. Kirsch,et al.  Crystal structure of the BMP-2–BRIA ectodomain complex , 2000, Nature Structural Biology.

[39]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[40]  M. Fürthauer,et al.  Equivalent genetic roles for bmp7/snailhouse and bmp2b/swirl in dorsoventral pattern formation. , 2000, Development.

[41]  W. Talbot,et al.  Essential role of Bmp7 (snailhouse) and its prodomain in dorsoventral patterning of the zebrafish embryo. , 2000, Development.

[42]  T. Bouwmeester,et al.  The smad5 mutation somitabun blocks Bmp2b signaling during early dorsoventral patterning of the zebrafish embryo. , 1999, Development.

[43]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[44]  L. Zon,et al.  The molecular nature of zebrafish swirl: BMP2 function is essential during early dorsoventral patterning. , 1997, Development.

[45]  A. Gressner,et al.  Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. , 1997, Clinical chemistry.

[46]  K. Miyazono,et al.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins. , 1997, Nature.

[47]  J. Massagué,et al.  Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs , 1995, Molecular and cellular biology.

[48]  J. Massagué,et al.  GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex. , 1995, The EMBO journal.

[49]  P. Weissberg,et al.  Active and acid-activatable TGF-β in human sera, platelets and plasma , 1995 .

[50]  M. Westerfield.  The zebrafish book : a guide for the laboratory use of zebrafish (Danio rerio) , 1995 .

[51]  P. Weissberg,et al.  Active and acid-activatable TGF-beta in human sera, platelets and plasma. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[52]  J. Massagué,et al.  Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells , 1994, Molecular and Cellular Biology.

[53]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[54]  R Wieser,et al.  Mechanism of activation of the TGF-beta receptor. , 1994, Nature.

[55]  R. Derynck,et al.  Determination of type I receptor specificity by the type II receptors for TGF-beta or activin. , 1993, Science.

[56]  J. Massagué,et al.  Betaglycan presents ligand to the TGFβ signaling receptor , 1993, Cell.

[57]  J. Massagué,et al.  Betaglycan presents ligand to the TGF beta signaling receptor. , 1993, Cell.

[58]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.

[59]  J. Massagué,et al.  Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. , 1990, The Journal of biological chemistry.

[60]  J. Massagué,et al.  Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. , 1990, The Journal of biological chemistry.